Novavax
Sanofi Invests $500M in Novavax’s Covid Vaccine, Exploring Commercialization and Flu Combination
Sanofi, Novavax, Covid vaccine, commercialization, flu combination, $500M investment
Novavax Secures $400 Million Settlement with Gavi to Resolve COVID-19 Vaccine Contract Dispute
Gavi, Novavax, Settlement and Resettlement